Sinclair Pharma Regulatory News (SPH)

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Alan Olby

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Sinclair Pharma plc

b.

LEI

213800BNMD7JVMHW1772

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary Shares of 1p each

ISIN: GB0033856740

b.

Nature of the transaction

Award of shares under the Company's 2013 Bonus Plan

c.

Price(s) and volume(s)

d.

Aggregated information

· Aggregated volume

· Price

N/A

e.

Date of the transaction

2016-09-26

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)